Switching from branded to generic glatiramer acetate: two-year clinical data from the GATE trial further support the continued efficacy and tolerability of generic glatiramer acetate

被引：0
|
作者：
Cohen, J. A. [1 ]
Belova, A. [2 ]
Barkhof, F. [3 ]
Wolf, C. [4 ]
van den Tweel, E. R. W. [5 ]
Oberye, J. J. L. [5 ]
Mulder, R. [5 ]
Koper, N. P. [5 ]
Selmaj, K. [6 ]
机构：
[1] Cleveland Clin, Mellen Ctr, Cleveland, OH 44106 USA
[2] Res Inst Traumatol & Othopaedy, Funct Diagnost, Nizhnii Novgorod, Russia
[3] Vrije Univ Amsterdam Med Ctr, Radiol, Amsterdam, Netherlands
[4] Lycalis Sprl, Brussels, Belgium
[5] Synthon BV, Nijmegen, Netherlands
[6] Med Univ Lodz, Lodz, Poland
来源：
MULTIPLE SCLEROSIS JOURNAL | 2015年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1050
引用
收藏
页码：536 / 537
页数：2
相关论文
共 40 条
  • [31] Two-year results from the globe trial in patients with hepatitis B: Greater clinical and antiviral efficacy for telbivudine (LDT) vs. lamivudine
    Lai, Ching-Lung
    Gane, Edward
    Hsu, Chao-Wei
    Thongsawat, Satawat
    Wang, Yumin
    Chen, Yagang
    Heathcote, Elizabeth J.
    Rasenack, Jens
    Bzowej, Natalie
    Naoumov, Nikolai
    Zeuzem, Stefan
    Di Bisceglie, Adrian
    Chao, George C.
    Constance, Barbara A. Fielman
    Brown, Nathaniel A.
    HEPATOLOGY, 2006, 44 (04) : 222A - 222A
  • [32] Two-year data: Infliximab maintains clinical response in psoriatic arthritis patients - An analysis of the year 2 data from the infliximab multinational psoriatic arthritis controlled trial (impact)
    Antoni, CE
    Kavanaugh, A
    Kirkham, B
    Tutuncu, Z
    Burmester, GR
    Schneider, U
    Furst, DE
    Molitor, J
    Keystone, E
    Gladman, D
    Manger, B
    Wassenberg, S
    Weier, R
    Wallace, D
    Weisman, MH
    Kalden, JR
    Smolen, J
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 82 - 82
  • [33] Peginterferon beta-1a every 2 weeks demonstrated better clinical outcomes than glatiramer acetate once-daily in patients with RRMS: propensity score matching of phase 3 data from ADVANCE and CONFIRM
    Scott, T.
    Mokliatchouck, O.
    Castrillo-Viguera, C.
    Harrington, A.
    Naylor, M. L.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 901 - 901
  • [34] Two-Year Efficacy And Safety Of Velaglucerase Alfa In Patients With Type 1 Gaucher Disease Switching From Imiglucerase: Phase III Trial HGT-GCB-039 And Extension
    Crombez, Eric
    Kishnani, Priya
    Ben Turkia, Hadhami
    Gonzalez, Derlis
    Zimran, Ari
    Kabra, Madhulika
    Lukina, Elena
    Giraldo, Pilar
    Kisinovsky, Isaac
    Bavdekar, Ashish
    Ben Dridi, Marie-Francoise
    Gupta, Neerja
    MOLECULAR GENETICS AND METABOLISM, 2012, 105 (02) : S25 - S26
  • [35] Efficacy of Adjunctive Eslicarbazepine Acetate in Patients with Focal Seizures, According to Baseline Seizure Frequency: A Post-Hoc Analysis of Data from a Phase IV Clinical Trial
    Aboumatar, Sami
    Cantu, David
    Blum, David
    Zhang, Ian
    Grinnell, Todd
    NEUROLOGY, 2021, 96 (15)
  • [36] Long-term efficacy, safety and tolerability of secukinumab in children and adolescents with severe chronic plaque psoriasis: Two-year results from a Phase III double-blind, randomized controlled trial
    Krasowska, D.
    Gambichler, T.
    Cortes, C.
    Horev, A.
    Compagno, N.
    Dahale, S. S.
    Papanastasiou, P.
    Keefe, D.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (08) : 1616 - 1625
  • [37] Safety and efficacy of the polymer-based, paclitaxel-eluting TAXUS stent in complex lesions:: Two-year clinical results from the TAXUS v de novo trial
    Ellis, Stephen G.
    Cannon, Louis A.
    Mann, Tift
    Greenberg, Joel D.
    DeMaio, Samuel
    Goli, Vasudeva
    Knapp, William
    McGarry, Thomas
    Kutcher, Michael A.
    Koglin, Joerg
    Stone, Gregg W.
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (8A): : 142M - 143M
  • [38] Efficacy and tolerability of 3-and 6-month depot formulations of leuprorelin acetate for advanced prostate cancer in treatment-naive and pretreated patients: pooled data from two non-interventional studies.
    Ohlmann, Carsten Henning
    Gross-Langenhoff, Marco
    Tunn, Ulf W.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [39] Two-year long-term data on the efficacy and tolerability of dolutegravir-based regimens from the prospective multi-centre TESLA cohort study in ART-naive and pre-treated people living with HIV in Russia
    Basova, Anna
    Minaeva, Stella
    Sizova, Natalia
    Nagimova, Firaya
    Orlova-Morozova, Elena
    Radzikhovskaya, Margarita
    Shevchenko, Valeriy
    Maldonado-Doblado, Andres
    Jones, Bryn
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 103 - 105
  • [40] A Multicenter Study to Evaluate the Safety and Efficacy of a Stand-Alone Anterior Carbon I/F Cage for Anterior Lumbar Interbody Fusion Two-Year Results From a Food and Drug Administration Investigational Device Exemption Clinical Trial
    Li, Jingfeng
    Dumonski, Mark L.
    Liu, Qinyi
    Lipman, Adam
    Hong, Joseph
    Yang, Nuo
    Jin, Zhengshuai
    Ren, Yongxin
    Limthongkul, Worawat
    Bessey, Jason T.
    Thalgott, John
    Gebauer, Greg
    Albert, Todd J.
    Vaccaro, Alexander R.
    SPINE, 2010, 35 (26) : E1564 - E1570
1234